Review



matrix metallopeptidase 9  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems matrix metallopeptidase 9
    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and <t>MMP9</t> determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
    Matrix Metallopeptidase 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 125 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pmc13054578-81-14-19?v=R%26D+Systems
    Average 95 stars, based on 125 article reviews
    matrix metallopeptidase 9 - by Bioz Stars, 2026-06
    95/100 stars

    Images

    1) Product Images from "The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis"

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    Journal: Military Medical Research

    doi: 10.1016/j.mmr.2026.100010

    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
    Figure Legend Snippet: Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Techniques Used: Concentration Assay, Incubation, Ex Vivo, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Control, Bacteria

    Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
    Figure Legend Snippet: Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Techniques Used: Diagnostic Assay, Fluorescence, Comparison, Concentration Assay, Marker, Control, Incubation, Bacteria

    Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.
    Figure Legend Snippet: Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.

    Techniques Used: Infection



    Similar Products

    94
    Guangzhou JET Bio-Filtration human mmp-2 (matrix metalloproteinase 2) elisa kit
    Human Mmp 2 (Matrix Metalloproteinase 2) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/guangzhou+jet+bio-filtration___enzyme-linked-immunosorbent-assay-elisa-immunoassays-immunology?v=Guangzhou+JET+Bio-Filtration
    Average 94 stars, based on 1 article reviews
    human mmp-2 (matrix metalloproteinase 2) elisa kit - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    93
    Bioss anti actin
    Anti Actin, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pmc13181273-50-55-50?v=Bioss
    Average 93 stars, based on 1 article reviews
    anti actin - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    R&D Systems matrix metallopeptidase 9
    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and <t>MMP9</t> determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.
    Matrix Metallopeptidase 9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pmc13054578-81-14-19?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    matrix metallopeptidase 9 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    86
    Servicebio Inc mmp 13
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Mmp 13, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pmc13123509-648-54-55?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    mmp 13 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Synpeptide Co Ltd mmp degradable cross linking peptide ekn3gpqgiwgqkn3e
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Mmp Degradable Cross Linking Peptide Ekn3gpqgiwgqkn3e, supplied by Synpeptide Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pm42275570-186-9-16?v=Synpeptide+Co+Ltd
    Average 86 stars, based on 1 article reviews
    mmp degradable cross linking peptide ekn3gpqgiwgqkn3e - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Haoyuan Chemexpress Co Ltd recombinant human mmp 9
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Recombinant Human Mmp 9, supplied by Haoyuan Chemexpress Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pm42251873-59-0-12?v=Haoyuan+Chemexpress+Co+Ltd
    Average 86 stars, based on 1 article reviews
    recombinant human mmp 9 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    93
    Bioss mmp2 bioss bs 4599r
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Mmp2 Bioss Bs 4599r, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pm42138196-176-15-16?v=Bioss
    Average 93 stars, based on 1 article reviews
    mmp2 bioss bs 4599r - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology rat mmp 9
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Rat Mmp 9, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pmc13127318-42-0-8?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    rat mmp 9 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    86
    Servicebio Inc primary antibodies against mmp 1
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Primary Antibodies Against Mmp 1, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pm42075957-190-0-11?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    primary antibodies against mmp 1 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Janssen itz itraconazole bcs biopharmaceutics classification system hpmcas mmp hydroxypropyl methylcellulose acetate succinate
    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections <t>showing</t> <t>MMP-13</t> staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).
    Itz Itraconazole Bcs Biopharmaceutics Classification System Hpmcas Mmp Hydroxypropyl Methylcellulose Acetate Succinate, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mmp/pm42081178-2-0-36?v=Janssen
    Average 86 stars, based on 1 article reviews
    itz itraconazole bcs biopharmaceutics classification system hpmcas mmp hydroxypropyl methylcellulose acetate succinate - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Concentration-dependent change in the humoral inflammatory response following incubation with Escherichia coli ( E. coli ) in the ex vivo whole blood model. a Absolute plasma concentrations of IL-6, IL-8, and MMP9 determined by enzyme-linked immunosorbent assay. b Normalized values and EC 50 curve fit by BuC=0% and 50 000 CFU/ml E. coli= 100%, respectively, for IL-6, IL-8, and MMP9 as indicated by EC 50 (%) on the respective Y-axis. BuC indicates buffer control after 60 min incubation; numbers on the X-axis indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation; LPS indicates lipopolysaccharide (LPS) 100 ng/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, comparing all shown concentrations of E. coli bacteria and 100 ng/ml LPS with BuC. P -values are indicated above the respective data points. ⁎ P <0.05, ⁎⁎ P <0.01, ⁎⁎⁎ P <0.001. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Concentration Assay, Incubation, Ex Vivo, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Control, Bacteria

    Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Diagnostic performance for the detection of bacteremia, analyzing the neutrophil phenotype by determining the median fluorescence intensity (MFI) and the cellular response capacity (CRC) in comparison with traditional markers of humoral inflammation (IL-6, IL-8, MMP9). a Comparison of receiver operating characteristic (ROC) at 10,000 CFU/ml Escherichia coli ( E. coli ) with the respective 95% confidence interval (CI) and P -value, and half-maximal effective concentration (EC 50 ) as a function of the E. coli concentration. b Detailed comparison of the EC 50 as a function of the E. coli concentration. c Exemplary comparison of EC 50 curve fit after normalization as indicated by EC 50 (%) on the respective Y-axis to BuC=100% and 50 000 CFU/ml E. coli =0% for the humoral marker IL-6 (the IL-6 values were multiplied by −1 before EC 50 calculation to facilitate comparability with the CRC) and the change in neutrophil phenotype represented by CD11b CRC. BuC indicates buffer control after 60 min incubation; numbers on the X-axis of c indicate E. coli bacteria in concentrations of 2000 to 50 000 CFU/ml after 60 min incubation. Values are shown as median and interquartile range. n =8. Statistical analysis was performed using the Kruskal-Wallis test with Dunn’s post-hoc test, evaluating the EC 50 of IL-8, MMP9, the MFI, and CRC of CD10, CD11b, and CD62L in comparison to the EC 50 of IL-6. P -values are indicated above the respective data points. ⁎ P <0.05. CFU. Colony-forming units; IL. Interleukin; MMP9. Matrix metallopeptidase 9.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Diagnostic Assay, Fluorescence, Comparison, Concentration Assay, Marker, Control, Incubation, Bacteria

    Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.

    Journal: Military Medical Research

    Article Title: The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis

    doi: 10.1016/j.mmr.2026.100010

    Figure Lengend Snippet: Clinical specifications and parameters over all time points of the sepsis cohort. a Suspected infection cause of sepsis. b Distribution of the individual score points of the Sequential Organ Failure Assessment (SOFA) score. c Total SOFA score. d-h Traditional and humoral markers of inflammation: leukocytes and neutrophil-lymphocyte ratio ( d ), C-reactive protein (CRP) and procalcitonin (PCT) ( e ), interleukin-6 (IL-6) and interleukin-8 (IL-8) ( f ), serum amyloid A (SAA) and calprotectin ( g ), matrix metallopeptidase 9 (MMP9) and myeloperoxidase (MPO) ( h ). Values are shown as median and interquartile range. n =14. CNS. Central nervous system; HV. Healthy volunteers.

    Article Snippet: For the samples of the ex vivo whole blood model, the plasma concentrations of matrix metallopeptidase 9 (MMP9, #DY911, R&D Systems, Minneapolis, USA), IL-6 (#555220, BD Biosciences, San Jose, USA), and IL-8 (#DY208, R&D Systems) were measured in citrate-anticoagulated plasma using enzyme-linked immunosorbent assay according to the respective manufacturer’s instructions.

    Techniques: Infection

    Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections showing MMP-13 staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).

    Journal: Bioactive Materials

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    doi: 10.1016/j.bioactmat.2026.03.017

    Figure Lengend Snippet: Efficacy of mechanically sensitized OBNC microspheres in the treatment of osteoarthritis. A) Diagram of OBNC microspheres self-adaptive filling of a cartilage injury site to promote cartilage repair and regeneration. B) Representative images of H&E staining. C) OARSI scores of articular cartilage in each group. D) Representative images of safranin O-fast green staining. E) Relative glycosaminoglycan (GAG) content in each group. F) Representative sections showing TUNEL staining for apoptotic cells. G) Quantification of TUNEL-positive cells. H) Representative sections showing Collagen II staining for chondrocytes. I) Relative collagen II expression in each group. J) Representative sections showing MMP-13 staining of chondrocytes. K) Relative MMP-13 expression in each group. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01).

    Article Snippet: Antigen retrieval was performed by microwaving in citrate buffer for 10 min. Endogenous peroxidase activity was blocked by incubating the sections with 3% hydrogen peroxide for 10 min, and non-specific binding was blocked with 3% BSA for 1 h. The sections were incubated overnight at 4 °C with primary antibodies to Collagen II and MMP-13 (ServiceBio, China), washed, and incubated for 1 h with HRP-labeled secondary antibodies (ServiceBio, China).

    Techniques: Staining, TUNEL Assay, Expressing